EUVIMEDEUVIMED entdecken
Open Access

The clinical significance of SIGLEC1 mRNA levels derived from peripheral leukocytes in autoimmune thyroid diseases and type 1 diabetes

Mami Gamo-Kawasaki, Shiori Kawai, Ayano Takei, Kazunori Fukuda, Mototaka Yamauchi, Kenji Hara, Takafumi Tsuchiya, Kohzo Takebayashi, Koshi Hashimoto

Endocrine Journal · 2026

DOI: 10.1507/endocrj.ej25-0639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Journal, 2026. Verfasst von Mami Gamo-Kawasaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, RNA, Messenger, Sialic Acid Binding Ig-like Lectin 1, Graves Disease. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1RNA, MessengerSialic Acid Binding Ig-like Lectin 1Graves DiseasePolyendocrinopathies, AutoimmuneHashimoto DiseaseThyroiditis, AutoimmuneLeukocytesHumansFemaleMaleAdultCross-Sectional StudiesMiddle AgedAutoantibodies

Stichwörter der Autor:innen

Autoimmune polyglandular syndrome type 3 (APS3)Autoimmune thyroid diseases (AITD)Sialic acid-binding immunoglobulin-like lectin 1 (SIGLEC1)Type 1 diabetes (T1DM)

Substanzen

RNA, MessengerSialic Acid Binding Ig-like Lectin 1SIGLEC1 protein, humanAutoantibodies

Autor:innen und Institutionen

  • Department of Diabetes and Endocrinology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan.
  • Collaborative Research Center, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Gamo-Kawasaki, M., Kawai, S., Takei, A., Fukuda, K., Yamauchi, M., Hara, K., Tsuchiya, T., Takebayashi, K., & Hashimoto, K. (2026). The clinical significance of SIGLEC1 mRNA levels derived from peripheral leukocytes in autoimmune thyroid diseases and type 1 diabetes. Endocrine Journal. https://doi.org/10.1507/endocrj.ej25-0639

Vancouver

Gamo-Kawasaki M, Kawai S, Takei A, Fukuda K, Yamauchi M, Hara K, et al. The clinical significance of SIGLEC1 mRNA levels derived from peripheral leukocytes in autoimmune thyroid diseases and type 1 diabetes. Endocrine Journal. 2026. doi:10.1507/endocrj.ej25-0639

BibTeX
@article{GamoKawasaki2026,
  author = {Gamo-Kawasaki, Mami and Kawai, Shiori and Takei, Ayano and Fukuda, Kazunori and Yamauchi, Mototaka and Hara, Kenji and Tsuchiya, Takafumi and Takebayashi, Kohzo and Hashimoto, Koshi},
  title = {The clinical significance of SIGLEC1 mRNA levels derived from peripheral leukocytes in autoimmune thyroid diseases and type 1 diabetes},
  journal = {Endocrine Journal},
  year = {2026},
  doi = {10.1507/endocrj.ej25-0639}
}
Kostenlos starten →